Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001393905-19-000201

← back to feed
Filed
Jun 17, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Jun 17, 2019 112.72M sh
Shares Diluted Q3 2019 · Dec 31, 2018 87.37M sh
Shares Diluted Q3 2019 · Dec 31, 2018 66.32M sh
Shares Diluted Q3 2019 · Dec 31, 2017 28.7M sh
Shares Diluted Q3 2019 · Dec 31, 2017 27.67M sh
Cash And Equivalents Q3 2019 · Dec 31, 2018 $283.37K
Cash And Equivalents Q3 2019 · Mar 31, 2018 $109.43K
Cash And Equivalents Q3 2019 · Dec 31, 2017 $26.77K
Cash And Equivalents Q3 2019 · Mar 31, 2017 $32.28K
Current Liabilities Q3 2019 · Dec 31, 2018 $2.21M
Current Liabilities Q3 2019 · Mar 31, 2018 $1.98M
Total Liabilities Q3 2019 · Dec 31, 2018 $2.21M
Total Liabilities Q3 2019 · Mar 31, 2018 $1.98M
Current Assets Q3 2019 · Dec 31, 2018 $325.87K
Current Assets Q3 2019 · Mar 31, 2018 $109.43K
Total Assets Q3 2019 · Dec 31, 2018 $325.87K
Total Assets Q3 2019 · Mar 31, 2018 $109.43K
Eps Diluted Q3 2019 · Dec 31, 2018 $0.00
Eps Diluted Q3 2019 · Dec 31, 2018 −$0.01
Eps Diluted Q3 2019 · Dec 31, 2017 −$0.02
Eps Diluted Q3 2019 · Dec 31, 2017 −$0.04
Eps Basic Q3 2019 · Dec 31, 2018 $0.00
Eps Basic Q3 2019 · Dec 31, 2018 −$0.01
Eps Basic Q3 2019 · Dec 31, 2017 −$0.02
Eps Basic Q3 2019 · Dec 31, 2017 −$0.04
Sga Expense Q3 2019 · Dec 31, 2018 $159.97K
Sga Expense Q3 2019 · Dec 31, 2018 $439.75K
Sga Expense Q3 2019 · Dec 31, 2017 $107.55K
Sga Expense Q3 2019 · Dec 31, 2017 $475.72K
Rd Expense Q3 2019 · Dec 31, 2018 $80.22K
Rd Expense Q3 2019 · Dec 31, 2018 $270.44K
Rd Expense Q3 2019 · Dec 31, 2017 $58.48K
Rd Expense Q3 2019 · Dec 31, 2017 $254.58K
Net Income Q3 2019 · Dec 31, 2018 $342.97K
Net Income Q3 2019 · Dec 31, 2018 −$692.51K
Net Income Q3 2019 · Dec 31, 2017 −$463.48K
Net Income Q3 2019 · Dec 31, 2017 −$1.16M